UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
FBR Capital Cuts Price Target on Athenahealth (ATHN) Following 2Q Miss
July 22, 2016 7:13 AM EDTFBR Capital reiterated a Market Perform rating on Athenahealth (NASDAQ: ATHN), and cut the price target to $140.00 (from $145.00), following the company's 2Q earnings report. Revenue was $262 million, below the consensus of $274 million. Non-GAAP adjusted EPS was $0.34, compared with the consensus of $0.42.
Analyst Steven Halper... More
Deutsche Bank Downgrades athenahealth (ATHN) to Hold
July 22, 2016 6:58 AM EDTDeutsche Bank downgraded athenahealth (NASDAQ: ATHN) from Buy to Hold with a price target of $147.00 (from $165.00). Analyst George Hill pointed out disturbing underlying performance metrics.
"Athena reported concerning Q2 results after market close, where the revenue and earnings miss was among the... More
